This site is intended for our US customers.

If you wish to visit our International site, please choose your appropriate region using the selector in the top right of this page.

MosaiQ™ Overview

MosaiQ™ by Quotient

MosiaQ™ is the world’s first fully automated and integrated testing platform for both blood grouping and donor disease screening. MosaiQ harnesses traditional serology and advanced microarray technology to deliver safe and comprehensive antigen typing and blood-group antibody detection.

Quotient’s dedication to transfusion diagnostics is bolstered by over 30 years of experience in the field. Our strong heritage and focus enables us to create innovative solutions that anticipate and address our customers’ needs.

The MosaiQ platform provides:

Rapid results: targeted at less than 35 minutes per sample
Advanced processing: real-time resource management 

Quotient’s dedication to transfusion diagnostics is bolstered by over 30 years of experience in the field. Our strong heritage and focus enables us to create innovative solutions that anticipate and address our customers’ needs.

At the heart of this groundbreaking technology is the MosaiQ microarray.

Each microarray can contain up to 132 probes, offering unmatched testing capability.

The MosaiQ Immunohematology (IH) Microarray delivers comprehensive red cell antigen typing and a vast array of red cells for antibody detection and exclusion, all on a single Microarray.

The MosaiQ transfusion transmissible infection screening (TTI) Microarray provides full mandatory donor serological disease screening capability, all on a bespoke microarray.

The Molecular Disease Screening (MDS) Microarray. Development of a separate Microarray to provide full mandated molecular disease screening is underway.

 

How can MosaiQ benefit my lab?

How does the microarray work?

What does the future of MosaiQ look like?